Clinical Trials Directory

Trials / Completed

CompletedNCT02556177

Advanced MRI Applications for Mild Traumatic Brain Injury-Phase 2

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
477 (actual)
Sponsor
GE Healthcare · Industry
Sex
All
Age
15 Years – 50 Years
Healthy volunteers
Accepted

Summary

This is an open-label, non-randomized, prospective, multi-site, parallel group (segment), hypothesis-generating study designed to collect data that will aid in future scientific and engineering exploration of correlations between clinical neuropsychological assessments and GE Research Pack II advanced MR imaging in mTBI patients. The results are primarily intended for scientific inquiry and engineering development purposes, and may be used in future regulatory submissions.

Detailed description

This data-driven study is being conducted for hypothesis generation in population of mild traumatic brain injury (mTBI) patients using advanced applications for magnetic resonance imaging (MRI) developed by the Sponsor, GE Healthcare (GEHC), and corresponding clinical neuropsychological assessments. This data is intended for future use in development of specialized MR acquisition, reconstruction, and processing software intended to identify mTBI biomarkers.

Conditions

Interventions

TypeNameDescription
PROCEDUREMRIMRI scanning

Timeline

Start date
2015-11-01
Primary completion
2018-01-31
Completion
2018-01-31
First posted
2015-09-22
Last updated
2019-09-10
Results posted
2019-09-10

Locations

7 sites across 1 country: United States

Source: ClinicalTrials.gov record NCT02556177. Inclusion in this directory is not an endorsement.